DocuSign Envelope ID: C02C7E10-0973-43F9-A200-8203256D8AA2 ## Annual Report & Financial Statements Year Ended 31 December 2021 ## **IN SAFE HANDS** Registered Charity Number: 1152340 DocuSign Envelope ID: C02C7E10-0973-43F9-A200-8203256D8AA2 _Year Ended 31 December 2021_ _TRUSTEES’ ANNUAL REPORT_ ## **Our Mission** ## **Who are we** **MARS’ mission is to transform the healthcare experience of a sick patient. This is done by advocating and easing the journey of the patient through the medical system.** MARS was founded in 2012 by Rabbi Hershel Grunfeld, after having experienced emotional turbulence when supporting two close relatives through critical illness. He realised the need for medical advocacy and support and competently undertook to match sick people with the best hospitals, physicians and treatments available for their conditions, either in the UK or, in rare cases abroad. Before he knew it, this ad-hoc help had grown into a fully-fledged, multi-faceted support organisation. Simply put, the goal of MARS has become that **‘the patient should understand the doctor, and the doctor should understand the patient’.** In other words, MARS is helping patients navigate the complex world of medicine and physical health; have access to lifesaving medicines and advocating for the best care available. At the same time, MARS is ensuring that the medical team understands the needs of the patient; especially those with unique cultural, religious and/or linguistic needs. ## **Who we help** MARS serves people from ethnic minority communities, focusing particularly but not exclusively, on the Orthodox Jewish Community. This community has unique religious and cultural needs that may be unfamiliar to the medical world. This community also includes recent immigrants to the UK, meaning that both the language and the culture are unfamiliar to them. Geographically, we are based in London, but we receive calls from all over England and have liaison officers located in other areas of the UK such as Essex, Manchester and Gateshead. _Having worked closely with MARS service, I can see that you offer tremendous benefit to patients. Your 24/7 availability and service gives your community access to the advice at their time of need and your close relationship with various leading clinicians means that access to medical care is optimised. From a clinic and hospital perspective, it is also extremely useful to have a single point of contact to discuss complex care needs and patients._ _Mr Sam Rajaratnam – FRCS Consultant Orthopaedic Surgeon & Director of Orthopaedics Schoen Clinic London_ 03 02 DocuSign Envelope ID: C02C7E10-0973-43F9-A200-8203256D8AA2 _Year Ended 31 December 2021_ _TRUSTEES’ ANNUAL REPORT_ **Struggling with illness is like climbing Mount Everest alone on a foggy day, along a narrow path wrought with stones and other obstacles. Every decision is taken with fear and confusion, knowing that the end results can be critical.** **We at MARS try to accompany the climbers, remove their loneliness, and shine light on their challenges. It is still not easy but at least no one is alone.** ## **At MARS, a typical day can involve a wide range of issues, spanning many different aspects of medicine and physical health. These include:** - Supporting patients who request assistance with any type of medical diagnosis from moderate to acute. - Offering patients with acute diagnosis more specialist support. - Proposing options to research treatment routes for rare medical disorders and genetic conditions. - Advising women who have received a prenatal diagnosis regarding a foetal condition or given birth to a child with a congenital condition. - Helping people with no internet access to receive additional information on their medical challenge to be able to make conscious decisions and choices. - Addressing any issues that may impair a person’s physical health and well-being. **Along with their overwhelming emotions, patients are often faced with a number of practical challenges that compound an already challenging situation.** ## **What we do** - The NHS has limited manpower and resources, so that even prior to COVID, the average waiting time for some urgent referrals could be as long as 6 months. Months that can spell the difference between life and death. - Patients may have difficulties understanding their medical diagnosis and prognosis. Whether this is due to difficulty with the medical jargon and terms, or – for the many immigrants to the UK – a simple linguistic obstacle. Such confusion does not lend itself to smooth and quality care. - Medical teams are often not familiar with the traditional values and culture of the patient. This creates friction and erodes critical trust between them and the patient. - Medical practitioners try their best, but may not have the resources available to access out-of-the box treatment options, which could possibly be the patient’s only hope. - **At MARS, we will step in and provide both emotional and practical support to give patients a higher standard of care, in the following ways:** - _**Advocacy and Connections**_ – We use the - connections we have made with doctors across the UK (and across the globe, if need be,) to match patients with the doctor most suited for their specific situation. We also help expedite urgent referrals and treatments. - _**Funding** –_ We help fund private treatment, additional - costs and medical transfers where needed, so that finances are never the reason for not getting the most appropriate and effective treatment. - _**Interpretation**_ – Interpretation services for patients - and families with limited English proficiency are available. - _**Guidance and Assistance** –_ When a patient reaches - out to us, we will designate a dedicated liaison who will guide them and support them throughout their medical journey. - _**Medical Records Review** –_ Sometimes, a patient will - benefit from receiving a second medical opinion and review of their prognosis. We help them obtain this second (or even third or fourth) opinion from specialists across the globe, to obtain a better understanding of the best course of action. • _**Medical Research** –_ We strive to keep abreast of the latest medical breakthroughs, developments, treatments and trials. We study the latest research and attend medical conferences either virtually or in person, alongside doctors so that we can guide patients on the best path for them. Sometimes this could mean advocating for patients to join medical trials that may be their last or only option. At other times, this may mean supporting patients who are groping in the dark with rare illnesses to find the little-known specialist or treatment option. is especially important, as many local people do not have access to regular media. Information is prepared in different languages with up to date information on relevant issues. • _**Interpretation**_ – Interpretation services for patients and families with limited English proficiency is available. - _**Holiday Clinics** –_ We fund private local walk-in GP - clinics during public and Jewish holidays when there is a reduction in GP services. _Rabbi Grunfeld and his fabulous team do a terrific job in making sure that people with skin problems get an appointment to get a diagnosis and treatment promptly. The feedback from those referred to me from MARS regarding the service they provide is always exemplary. It is very clear that they know they are in a safe pair of hands with MARS and are the receiving the right care in a timely way._ - _**Dedicated Case Workers**_ – We provide patients who - have long-term health conditions with a dedicated case worker who becomes familiar with their case and supports them. This ensures a continuity and consistency of care. _Professor Jemima Mellerio BSc MD FRCP Consultant Dermatologist & Honorary Professor of Paediatric Dermatology_ ## **Number of Calls Received** ## **Partners, Networking and Training** MARS works in partnership with the NHS, and many medical, social and welfare organisations, across England. On a global level, MARS has a range of contacts with other medical advocacy activists in both Europe and the USA, to ensure that all their clients can access the best possible care, irrespective of geographical boundaries. Staff and volunteers receive ongoing in-service training on how to manage and handle telephone requests and research medical information. They are also regular attendees at national and international medical conferences to ensure that they are up-to-date with newly-released medical information and cutting-edge technology. - _**Medical Transfers**_ – When a visitor falls ill in the UK, - we can arrange for their return home for treatment. In rare cases, we also arrange medically safe transfers to enable patients to access specialised treatment abroad. - _**24/7 Crisis intervention**_ - A medical crisis can - happen at any time, and our Intervention team is there to support anyone 24/7. - _**Raising Awareness**_ - We work to raise the awareness - in the local community on critical healthcare issues. This 04 05 DocuSign Envelope ID: C02C7E10-0973-43F9-A200-8203256D8AA2 _Year Ended 31 December 2021_ _TRUSTEES’ ANNUAL REPORT_ _From the time I first became involved with MARS, I have witnessed it grow and transform into a most valuable resource for worried parents struggling to find the right doctor, or getting the advice and reassurance they so desperately need for their loved ones. Without their sheer dedication, commitment and most of all professionalism, this venture could not have reached the pinnacle of success it has. G-d has blessed us with these selfless human beings who only think of what is best for others and never give up until they deliver this promise._ Professor Imran Mushtaq MB FRCS (Paed) Consultant Paediatric Urologist – Great Ormond Street Hospital ## **Main Areas of Health Enquiries Received** **----- Start of picture text -----**
Illness Gynaecology ENT Obstetrics
Percentage 24% 16% 13%
Number of people 616 410 334
Illness Oncology Orthopaedics Dermatology
Percentage 10% 7% 6%
Number of people 256 180 154
Illness Geriatric Optical Renal
Percentage 6% 5% 4%
Number of people 154 128 103
Illness Neurology Cardiology Pulmonary
Percentage 3% 3% 3%
Number of people 81 77 75
**----- End of picture text -----**
06 07 DocuSign Envelope ID: C02C7E10-0973-43F9-A200-8203256D8AA2 _Year Ended 31 December 2021_ _TRUSTEES’ ANNUAL REPORT_ ## **Highlights of 2021** **Elderly** **Women** **Breadwinners & Caregivers** **Young People** **1095 Children & Babies** ## **Our Key Developments** ## **Increased Personnel** serve to ensure that the community’s needs are understood, supported and accommodated. With the strain on the NHS, these networks are vital to maintain, allowing us to ensure that each patient is appropriately supported in their hour of need. We now have a team of 13 caseworkers, who are sensitive, caring and supportive. Our workers specialise in various fields of expertise. Our 3 Front Desk Operators have been trained to identify urgent cases to ensure that they are dealt with promptly. MARS is not looking to reinvent the wheel. We are merely seeking to ensure that every child/parent is supported with whichever medical diagnose they have received. MARS has built excellent relationships with both local and international agencies, organisations and health services. Our phones are monitored 24/7 and we have two senior caseworkers who are available at unorthodox hours. A team of 25 trained volunteers are available to act as chaperons, offer general support and assist with household help, including arranging meals and food provision for families. Most recently, MARS have seen first-hand the incredible support that YL Hearts provides to American children who suffer from congenital heart disease (CHD) and their families. In recent months, MARS have worked tirelessly with YL Hearts to support them in establishing a local branch in London. In March 2022, a private launch of a UK wing of YL Hearts was held in conjunction with MARS, attended by renowned cardiologists who pledged their support to the many families who were in attendance. ## **Expansion of Offices & Improving IT** MARS has commenced it’s plans to expand its offices to accommodate the growing team and the newly evolving needs of patients. This is in conjunction with its modernising of its digital systems and ensuring all records of patients are being kept centrally in line with GDPR. Further connections have been established with Refuah Helpline (USA); Chaim Medical Centre (USA), and Rabbi Firer of Ezra Le’Marpeh (Israel). An additional floor will be made available to accommodate the case workers; family space where relatives can meet with MARS experts to discuss difficult diagnoses and plan their medical journey. Other rooms to be incorporated will include a conference room for training, both in person and virtually and there is a possibility that we will be able to provide a children’s play area ## **Evaluation & Feedback** We measure outcomes based on feedback from service users, medical professionals (as on our website) and local community leaders. We use this feedback to refine and improve our services for current and future patients. We recognise that it is difficult to conduct personal interviews and gather survey responses from patients and their families during their time of crisis. Aside for it being an inappropriate time to approach beneficiaries, a majority will prefer anonymity and are reluctant to expose their struggles. ## **Broader Networking Circle** MARS continues to arrange meetings with senior health care professionals, new medical consultants and nursing care homes to establish strong relationships and forge positive lines of communication, which are essential during times of need. Where possible, we encourage beneficiaries to keep us updated via, email, letter or phone call. We record all feedback, complaints and queries in line with GDPR and monitor our services accordingly. These are presented and discussed in our monthly management meetings. To date, MARS maintains close contact with local hospitals including Barts, Great Ormond Street, Royal London, Homerton, Royal Free, Newham and University College, amongst many others. These connections 9 8 DocuSign Envelope ID: C02C7E10-0973-43F9-A200-8203256D8AA2 _Year Ended 31 December 2021_ _TRUSTEES’ ANNUAL REPORT_ ## **Case Studies** ## **MARS saves a life** **MARS did not get fazed.** Mr B, on a routine doctor’s examination involving some blood work, was found to have a rare and unusual illness. After visiting many doctors and receiving numerous suggestions of treatments that failed to work, Mr B was at a loss. In his utter helplessness, Mr B found himself pulled into despair. A close friend who had heard of MARS, picked up the phone to Mr B recommending that he should contact them. Within 24 hours, Mr B’s file was on the desk of the dedicated MARS caseworker. In their review meeting, a specialist was soon identified. Within a minimal timeframe, a phone call was placed to the specialist’s private mobile phone presenting the scenario. After having studied Mr B’s scans and medical report, the specialist recommended an excellent doctor. There was one obstacle, however- the doctor in question was presently working in Dubai. MARS did not get fazed. Immediate action was undertaken to track the doctor in Dubai. Hours of research and networking were invested on behalf of Mr B, ultimately yielding results. MARS were thrilled to discover that the doctor in question was actually travelling to London the following week and was willing to meet with Mr B. The doctor did not have an established clinic in London, in which to host his new patient. This was not an issue for MARS who rose to the bait. MARS ordered the necessary equipment to their offices, where they transformed a room on their premises into a functional clinic to accommodate the needs of this one individual. After several months of treatment recommended by the specialist from Dubai, Mr B, thank G-d, is now a healthy man, free of the illness. Since this incident, the Doctor from Dubai has helped many more patients through MARS, both in-person and via Zoom where necessary. _My colleagues all said what a wonderful meeting it was, how impressed they were with each of you and how positive they were about working together to make the patient experience a better experience. I would like to think of this as a new beginning with regard to patient care._ _Dr. Laurence Blumberg_ A head of the family and much beloved father and grandfather, lay gravely ill in hospital. His children and loved ones surrounded his bed, as they knew his end was drawing near. A grandchild suggested that, despite the doctors’ bleaks prognosis, perhaps Rabbi Grunfeld of MARS could pull some strings and turn the tables. Within a short time, Rabbi Grunfeld was walking through the corridors of the hospital. Rabbi Grunfeld challenged the doctors to undertake an operation that could prolong the patient’s life. The doctor was opposed to the idea, as he believed the operation could have terrible consequences on the patient. Rabbi Grunfeld gave it thought and ingeniously came up with an alternative idea of how to operate in a way that would omit any grave side effects. This time, the doctor agreed there was hope, however refused to undertake the operation, as he felt too incompetent. Rabbi Grunfeld immediately sprang into action to obtain the expertise that was necessary. An alternative hospital and surgeon were contacted. The new surgeon admitted he was prepared to undertake this in the spirit of Rabbi Grunfeld’s dedication to people in need, as a display of respect for a man who does not sleep when it comes to helping a fellow man. The operation was carried out amidst the tears and prayers of the family. To the amazement of family and friends, the elderly man awoke! Three months later the beloved father and grandfather was healthy and strong enough to be able to dance at a wedding of his grandchild. **MARS' positive record.** Josh, an 8 year old boy, was brought into hospital in a serious situation and immediately transferred to the ICU in an NHS hospital. The doctor involved in the case gave a detailed rundown about the child’s difficult situation to the father, who could not handle the overwhelming information. Upon seeing the tear-filled, distraught and frightened eyes of the father, the doctor suggested that he contact Rabbi Grunfeld from MARS. Josh’s father readily agreed, yet replied that he did not have Rabbi Grunfeld’s number. The doctor was able to provide Rabbi Grunfeld’s number as she had it at hand when needed! **MARS is instrumental in bringing back doctors to NHS hospitals** Milly, a young woman, required an intricate and difficult surgery in an NHS hospital. Mars identified a suitable surgeon in this field with whom they had developed a close relationship in the past. Upon contacting the surgeon, MARS were told that he no longer worked in NHS hospital. However, due to his close affinity to MARS, and in response to the respect and appreciation MARS had awarded him over the years, he was prepared to go beyond his call of duty and reassign himself into an NHS hospital to undertake the operation. 10 11 DocuSign Envelope ID: C02C7E10-0973-43F9-A200-8203256D8AA2 _Year Ended 31 December 2021_ _TRUSTEES’ ANNUAL REPORT_ ## **Our vision** ## **Our plans for the next 5 years include:** a) Continue developing new case-management software, to ensure greater efficiency. ## **When ‘i’ is replaced by ‘we’** **Even ‘illness’ Becomes ‘wellness’** b) Employing additional staff to meet the growing need and support more patients. c) Carry out additional research, and network more widely and effectively with medical professionals. d) Commencing the refurbishment work to ensure that our Centre is amenable for patients, caseworkers and the professional team. e) Liaising with the Key personnel in the NHS PR department and individual doctors to increase their understanding of how health legislation affects ethnic minority communities, for example with end-of-life issues. f) Incorporate a fundraising strategy to enable MARS to increase its personnel, offer more training and supervision and support individuals. g) Facilitating support groups for various illnesses including cancer patients and their families. h) Encouraging the community to consider private medical insurance due to the constraints on the NHS. ## **Thank you** We owe immense gratitude to our devoted members in the community who work tirelessly behind the scenes to share the burden of Rabbi Grunfeld, ensure that we have the necessary funds, and offer their assistance in times of need. On behalf of our staff, volunteers and beneficiaries we would like to thank our donors. Your generous support has helped us be there for our community at critical times and give them the emotional and practical support when they needed it most. We pray for better times, both locally and globally and hope that you will be in a position to continue supporting this much needed service. _I have looked after patients from the MARS organisation for many years. The patients are always carefully selected and have already been given excellent advice by Rabbi Grunfeld and his team. There is careful coordination within the organisation about referrals and appointments and adopting a coordinated approach to offer the best patient care. It is clear that MARS serves as a key source of medical information and help for patients._ _Mr Arvind Vashisht MD MB BS FRCOG MA BA Urogynae Consultant, UCLH_ 13 12 DocuSign Envelope ID: C02C7E10-0973-43F9-A200-8203256D8AA2 **MARS ORG. LTD** ## **MARS ORG. LTD** ## **COMPANY LIMITED BY GUARANTEE** ## **TRUSTEES' ANNUAL REPORT (INCORPORATING THE DIRECTOR'S REPORT)** ## _**(continued)**_ ## **YEAR ENDED 31 DECEMBER 2021** ## **COMPANY LIMITED BY GUARANTEE** ## **TRUSTEES' ANNUAL REPORT (INCORPORATING THE DIRECTOR'S REPORT)** _**(continued)**_ ## **YEAR ENDED 31 DECEMBER 2021** ## **STRUCTURE, GOVERNANCE AND MANAGEMENT** ## **Governing document** The charity is controlled by its governing document, its memorandum and articles of association, and constitutes a limited company, limited by guarantee, as defined by companies act 2006. ## **Organisation** The day-to-day affairs of the charity are administered by the trustees. None of the trustees who are also the directors have any beneficial interest in the company. ## **Recruitment and appointment of new trustees** It is not currently the intention of the trustees of the charity to appoint new trustees. Should this situation change in the future, the trustees will apply suitable recruitment and training procedures. ## **SMALL COMPANY PROVISIONS** This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption. 28/10/2022 The trustees' annual report was approved on .............................. and signed on behalf of the board of trustees by: Mr H Grunfeld Trustee ## **Risk Management** The trustees have identified and reviewed the major risks to which the charity is exposed, in particular those related to the operations and finance of the charity, and are satisfied that systems are in place to mitigate those risks. ## **Investments powers, policy and performance** The charity places surplus funds in a bank deposit account. It is the view of the trustees that due to the rapid turnover of funds it would not be prudent to invest in any other type of account as the charity requires immediate access to its funds. ## **Governance and internal control** The power of appointing new or additional Trustees hereof or removing Trustees is vested in the persons who are for the time being the trustees. ## **Public benefit** The Trustees confirm their compliance with their duty to have due regard to the public benefit guidance published by the Charity Commission when reviewing the Charity's aims and objectives and in planning future activities. ## **Financial review** The financial position of the Charity is satisfactory. Income and donations aggregated £900,113. Total resources expended were £883,059 resulting in a net surplus of £17,054 for the year and total reserves of £324,170 ( _2020 - £307,116_ ). ## **Reserves** The Trustees have examined the charity's requirements for reserves in light of the main risks to the organisation. It has established a policy whereby the unrestricted funds not committed or invested in tangible fixed assets held by the charity should be between 3 and 6 months of the expenditure. Budgeted expenditure for 2022 is £1.2m and therefore the target is £300,000 to £600,000 in unrestricted reserve funds. The reserves are needed to meet the working capital requirements of the charity and the Management Committee are confident that at this level they would be able to continue the current activities of the charity in the event of a significant drop in funding. The present level of unrestricted reserves available to the charity of £220,000 therefore falls short of this target level. Although the strategy is to continue to build reserves through planned operating surpluses, the trustees are aware that it is unlikely that the target range can be reached for at least two years. In the short term the trustees have also considered the extent to which existing activities and expenditure could be curtailed, should such circumstances arise. 14 15 DocuSign Envelope ID: C02C7E10-0973-43F9-A200-8203256D8AA2 ## **MARS ORG. LTD** ## **COMPANY LIMITED BY GUARANTEE** ## **INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF MARS ORG. LTD** ## **YEAR ENDED 31 DECEMBER 2021** I report to the trustees on my examination of the financial statements of MARS ORG. LTD ('the charity') for the year ended 31 December 2021. ## **RESPONSIBILITIES AND BASIS OF REPORT** As the trustees of the company (and also its directors for the purposes of company law) you are responsible for the preparation of the financial statements in accordance with the requirements of the Companies Act 2006 ('the 2006 Act’). Having satisfied myself that the accounts of the company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of the charity’s accounts as carried out under section 145 of the Charities Act 2011 (‘the 2011 Act’). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act. ## **INDEPENDENT EXAMINER'S STATEMENT** Since the charity’s gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the 2011 Act. I confirm that I am qualified to undertake the examination because I am a member of the Institute of Chartered Accountants in England and Wales (ICAEW), which is one of the listed bodies. I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe: 1. accounting records were not kept in respect of the charity as required by section 386 of the 2006 Act; or 2. the financial statements do not accord with those records; or ## **MARS ORG. LTD** ## **COMPANY LIMITED BY GUARANTEE** ## **STATEMENT OF FINANCIAL ACTIVITIES (INCLUDING INCOME AND EXPENDITURE ACCOUNT)** ## **YEAR ENDED 31 DECEMBER 2021** |||||**2021**|2020| |---|---|---|---|---|---| |||Unrestricted|Restricted||| |||funds|funds|**Total funds**|Total funds| ||**Note**|**£**|**£**|**£**|£| |**Income and endowments**|||||| |Donations and legacies|**5**|507,584|392,529|**900,113**|1,361,364| |Other trading activities|**7**|–|–|**–**|46,762| |||-------------------------------------|-------------------------------------|-------------------------------------|-----------------------------------------------| |**Total income**||507,584|392,529|**900,113**|1,408,126| |||=====================================|=====================================|=====================================|===============================================| |**Expenditure**|||||| |Expenditure on raising funds:|||||| |Costs of raising donations and|||||| |legacies|**8**|(25,530)|–|**(25,530)**|(117,594)| |Expenditure on charitable activities|**9,10**|(472,524)|(385,005)|**(857,529)**|(1,026,961)| |||-------------------------------------|-------------------------------------|-------------------------------------|-----------------------------------------------| |**Total expenditure**||(498,054)|(385,005)|**(883,059)**|(1,144,555)| |||=====================================|=====================================|=====================================|===============================================| |||-------------------------------------|-------------------------------------|-------------------------------------|-----------------------------------------------| |**Net income and net movement in**|**funds**|9,530|7,524|**17,054**|263,571| |||=====================================|=====================================|=====================================|===============================================| |**Reconciliation of funds**|||||| |Total funds brought forward||212,468|94,648|**307,116**|43,545| |||-------------------------------------|-------------------------------------|-------------------------------------|-----------------------------------------------| |**Total funds carried forward**||221,998|102,172|**324,170**|307,116| |||=====================================|=====================================|=====================================|===============================================| The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities. 3. the financial statements do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a ‘true and fair' view which is not a matter considered as part of an independent examination; or 4. the financial statements have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102). I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached. David Goldberg FCA DChA Independent Examiner New Burlington House 1075 Finchley Road London NW11 0PU 28/10/2022 Date: …………………….. **The notes on pages to form part of these financial statements.** 16 17 DocuSign Envelope ID: C02C7E10-0973-43F9-A200-8203256D8AA2 ## **MARS ORG. LTD** ## **COMPANY LIMITED BY GUARANTEE STATEMENT OF CASH FLOWS** ## **YEAR ENDED 31 DECEMBER 2021** |**STATEMENT OF CASH FLOWS**
**YEAR ENDED 31 DECEMBER 2021**||| |---|---|---| ||**2021**|2020| ||**£**|£| |**CASH FLOWS FROM OPERATING ACTIVITIES**||| |Net income|**17,054**|263,571| |_Adjustments for:_||| |Depreciation of tangible fixed assets|**21,505**|7,544| |Interest payable and similar charges|**1,654**|2,425| |Accrued expenses|**7,200**|4,800| |_Changes in:_||| |Trade and other debtors|**(280,000)**|–| |Trade and other creditors|**29,065**|(10,788)| ||-------------------------------------|-------------------------------------| |Cash generated from operations|**(203,522)**|267,552| |Interest paid|**(1,654)**|(2,425)| ||-------------------------------------|-------------------------------------| |Net cash (used in)/from operating activities|**(205,176)**|265,127| ||=====================================|=====================================| |**CASH FLOWS FROM INVESTING ACTIVITIES**||| |Purchase of tangible assets|**(47,365)**|(9,259)| ||-------------------------------------|-------------------------------------| |Net cash used in investing activities|**(47,365)**|(9,259)| ||=====================================|=====================================| |**CASH FLOWS FROM FINANCING ACTIVITIES**||| |Proceeds from borrowings|**(5,514)**|50,001| ||-------------------------------------|-------------------------------------| |Net cash (used in)/from financing activities|**(5,514)**|50,001| ||=====================================|=====================================| |**NET (DECREASE)/INCREASE IN CASH AND CASH**||| |**EQUIVALENTS**|**(258,055)**|305,869| |**CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR**|**341,709**|35,840| ||-------------------------------------|-------------------------------------| |**CASH AND CASH EQUIVALENTS AT END OF YEAR**|**83,654**|341,709| ||=====================================|=====================================| 28/10/2022 **The notes on pages to form part of these financial statements.** 19 18 DocuSign Envelope ID: C02C7E10-0973-43F9-A200-8203256D8AA2 **MARS ORG. LTD** ## **MARS ORG. LTD** ## **COMPANY LIMITED BY GUARANTEE** ## **NOTES TO THE FINANCIAL STATEMENTS** ## **YEAR ENDED 31 DECEMBER 2021** ## **1. GENERAL INFORMATION** The charity is a public benefit entity and a private company limited by guarantee, registered in England and Wales and a registered charity in England and Wales. The address of the registered office is New Burlington House, 1075 Finchley Road, London, NW11 0PU, United Kingdom. ## **2. STATEMENT OF COMPLIANCE** These financial statements have been prepared in compliance with FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland', the Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (Charities SORP (FRS 102)) and the Companies Act 2006. ## **3. ACCOUNTING POLICIES** ## **Basis of preparation** The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity. ## **Going concern** There are no material uncertainties about the charity's ability to continue. ## **Judgements and key sources of estimation uncertainty** The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. There have been no material adjustments based on estimations and assumptions during the financial year. ## **Fund accounting** General unrestricted funds comprise the accumulated surplus or deficit on income and expenditure account. They are available for use at the discretion of the Trustees in furtherance of the general objectives of the Charity. ## **COMPANY LIMITED BY GUARANTEE** ## **NOTES TO THE FINANCIAL STATEMENTS** _**(continued)**_ ## **YEAR ENDED 31 DECEMBER 2021** ## **Resources expended** All expenditure is classified under the Charity's principal categories of charitable and other expenditure and by the type of expense. ## **Tangible assets** Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. ## **Depreciation** Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows: |Fixtures and fittings|-|15% reducing balance| |---|---|---| |Motor vehicles|-|15% reducing balance| |Computer equipment|-|33% reducing balance| ## **Financial instruments** A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the amount receivable or payable including any related transaction costs, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Current assets and current liabilities are subsequently measured at the cash or other consideration expected to be paid or received and not discounted. ## **4. LIMITED BY GUARANTEE** The charity is a company limited by guarantee and has no share capital. The liability of each trustee in the event of winding up is limited to £1. Restricted funds are funds subject to specific restricted conditions imposed by donors. Designated funds are funds which have been set at the discretion of the Trustees for specific purposes. There are no designated funds as at the Balance Sheet date. ## **Incoming resources** All donations and other income are recognised in the statement of financial activities (SOFA) of the charity on a receivable basis. 20 21 DocuSign Envelope ID: C02C7E10-0973-43F9-A200-8203256D8AA2 ## **MARS ORG. LTD** ## **COMPANY LIMITED BY GUARANTEE** ## **NOTES TO THE FINANCIAL STATEMENTS** _**(continued)**_ ## **YEAR ENDED 31 DECEMBER 2021** ## **5. DONATIONS AND LEGACIES** |**DONATIONS AND LEGACIES**|||| |---|---|---|---| ||Unrestricted|Restricted|**Total Funds**| ||Funds|Funds|**2021**| ||£|£|**£**| |**DONATIONS**|||| |Donations|507,584|336,395|**843,979**| |**GRANTS**|||| |Grants|–|56,134|**56,134**| ||-------------------------------------|-------------------------------------|-------------------------------------| ||507,584|392,529|**900,113**| ||=====================================|=====================================|=====================================| ||Unrestricted|Restricted|Total Funds| ||Funds|Funds|2020| ||£|£|£| |**DONATIONS**|||| |Donations|977,981|301,077|1,279,058| |**GRANTS**|||| |Grants|–|82,306|82,306| ||-------------------------------------|-------------------------------------|-----------------------------------------------| ||977,981|383,383|1,361,364| ||=====================================|=====================================|===============================================| |**ANALYSIS OF GRANTS RECEIVED**|||| |Grants received, included in the above, are as follows:|||| |||**2021**|2020| |||**£**|£| |Research grant||**56,134**|34,250| |Special case funding||**–**|48,056| |||-------------------------------|-------------------------------| |||**56,134**|82,306| |||===============================|===============================| ## **6. ANALYSIS OF GRANTS RECEIVED** ## **7. OTHER TRADING ACTIVITIES** Unrestricted **Total Funds** Unrestricted Total Funds Funds **2021** Funds 2020 £ **£** £ £ – **–** Other trading activities 46,762 46,762 ================ ================ =============================== =============================== **COSTS OF RAISING DONATIONS AND LEGACIES** Unrestricted **Total Funds** Unrestricted Total Funds Funds **2021** Funds 2020 £ **£** £ £ Fundraising costs 25,530 **25,530** 117,594 117,594 =============================== =============================== ===================================== ===================================== ## **8. COSTS OF RAISING DONATIONS AND LEGACIES** ## **MARS ORG. LTD** ## **COMPANY LIMITED BY GUARANTEE** ## **NOTES TO THE FINANCIAL STATEMENTS** _**(continued)**_ ## **YEAR ENDED 31 DECEMBER 2021** ## **9. EXPENDITURE ON CHARITABLE ACTIVITIES BY FUND TYPE** ||Unrestricted|Restricted|**Total Funds**| |---|---|---|---| ||Funds|Funds|**2021**| ||£|£|**£**| |Charitable activities|411,193|385,005|**796,198**| |Support costs|61,331|–|**61,331**| ||-------------------------------------|-------------------------------------|-------------------------------------| ||472,524|385,005|**857,529**| ||=====================================|=====================================|=====================================| ||Unrestricted|Restricted|Total Funds| ||Funds|Funds|2020| ||£|£|£| |Charitable activities|715,371|288,735|1,004,106| |Support costs|22,855|–|22,855| ||-------------------------------------|-------------------------------------|-----------------------------------------------| ||738,226|288,735|1,026,961| ||=====================================|=====================================|===============================================| ## **10. EXPENDITURE ON CHARITABLE ACTIVITIES BY ACTIVITY TYPE** Activities ||undertaken||**Total funds**|Total fund| |---|---|---|---|---| ||directly|Support costs|**2021**|2020| ||£|£|**£**|£| |Charitable activities|796,198|52,680|**848,878**|1,022,161| |Governance costs|–|8,651|**8,651**|4,800| ||-------------------------------------|-------------------------------|-------------------------------------|-----------------------------------------------| ||796,198|61,331|**857,529**|1,026,961| ||=====================================|===============================|=====================================|===============================================| |**ANALYSIS OF CHARITABLE ACTIVITIES**||||| ||||**2021**|2020| ||||**£**|£| |Charitable activities|||**193,458**|183,170| |Covid support|||**4,500**|254,518| |Medical support|||**265,152**|258,051| |Medical support through congregations|||**20,488**|91,238| |Covid awareness|||**16,010**|36,182| |Sustenance packages|||**32,282**|84,932| |Covid research|||**69,179**|20,947| |Family communication welfare|||**9,611**|12,105| |Publications|||**–**|24,485| |Special case funding|||**166,332**|23,472| |Holiday (Yom Tov) clinics|||**17,087**|15,006| |Marketing|||**2,099**|–| ||||-------------------------------------|-----------------------------------------------| ||||**796,198**|1,004,106| ||||=====================================|===============================================| ## **ANALYSIS OF CHARITABLE ACTIVITIES** ## **11.** 23 22 DocuSign Envelope ID: C02C7E10-0973-43F9-A200-8203256D8AA2 **MARS ORG. LTD** ## **MARS ORG. LTD** ## **COMPANY LIMITED BY GUARANTEE** ## **NOTES TO THE FINANCIAL STATEMENTS** _**(continued)**_ ## **YEAR ENDED 31 DECEMBER 2021** ## **12. ANALYSIS OF SUPPORT COSTS** |**ANALYSIS OF SUPPORT COSTS**|||| |---|---|---|---| ||Charitable||| ||activities|**Total 2021**|Total 2020| ||£|**£**|£| |Finance costs|1,654|**1,654**|2,425| |Governance costs|8,651|**8,651**|4,800| |Legal and professional fees|29,521|**29,521**|8,084| |Depreciation|21,505|**21,505**|7,546| ||-------------------------------|-------------------------------|-------------------------------| ||61,331|**61,331**|22,855| ||===============================|===============================|===============================| |**NET INCOME**|||| |Net income is stated after charging:|||| |||**2021**|2020| |||**£**|£| |Depreciation of tangible fixed assets||**21,505**|7,546| |Fees payable for the audit of the financial statements||**–**|4,800| |||===============================|==========================| |**INDEPENDENT EXAMINATION FEES**|||| |||**2021**|2020| |||**£**|£| |Fees payable to the independent examiner for:|||| |Independent examination of the financial statements||**7,200**|–| |||==========================|================| |**STAFF COSTS**|||| |||**2021**|2020| |||**£**|£| |Wages and salaries||**57,595**|53,375| |Social security costs||**1,810**|–| |||-------------------------------|-------------------------------| |||**59,405**|53,375| |||===============================|===============================| ## **13. NET INCOME** ## **14. INDEPENDENT EXAMINATION FEES** ## **15. STAFF COSTS** The average monthly number of employees during the year was 8 (2020: 8). No salaries of £60,000 or over were paid during the year. ## **16. TRUSTEE REMUNERATION AND EXPENSES** No remuneration or other benefits from employment with the charity or a related entity were received by the trustees. ## **COMPANY LIMITED BY GUARANTEE** ## **NOTES TO THE FINANCIAL STATEMENTS** _**(continued)**_ ## **YEAR ENDED 31 DECEMBER 2021** ## **17. TANGIBLE FIXED ASSETS** |**TANGIBLE FIXED ASSETS**||||| |---|---|---|---|---| ||Fixtures and|Motor||| ||fittings|vehicles|Equipment|**Total**| ||£|£|£|**£**| |**Cost**||||| |At 1 January 2021|33,926|10,650|8,779|**53,355**| |Additions|1,265|–|46,100|**47,365**| ||-------------------------------|-------------------------------|-------------------------------|-------------------------------------| |**At 31 December 2021**|35,191|10,650|54,879|**100,720**| ||===============================|===============================|===============================|=====================================| |**Depreciation**||||| |At 1 January 2021|9,414|2,254|5,249|**16,917**| |Charge for the year|3,867|1,260|16,378|**21,505**| ||-------------------------------|-------------------------------|-------------------------------|-------------------------------------| |**At 31 December 2021**|13,281|3,514|21,627|**38,422**| ||===============================|===============================|===============================|=====================================| |**Carrying amount**||||| |**At 31 December 2021**|21,910|7,136|33,252|**62,298**| ||===============================|===============================|===============================|=====================================| |At 31 December 2020|24,512
===============================|8,396
===============================|3,530
===============================|36,438
=====================================| ## **18. DEBTORS** |**DEBTORS**||| |---|---|---| ||**2021**|2020| ||**£**|£| |Pledges|**280,000**|-| |Other debtors|**5,289**|5,289| ||-------------------------------|-------------------------------| ||**285,289**|5,289| ||=====================================|==========================| |**CREDITORS:** **amounts falling due within one year**||| ||**2021**|2020| ||**£**|£| |Bank loans and overdrafts|**9,600**|6,299| |Accruals and deferred income|**62,584**|26,319| ||-------------------------------|-------------------------------| ||**72,184**|32,618| ||===============================|===============================| |**CREDITORS:** **amounts falling due after more than one year**||| ||**2021**|2020| ||**£**|£| |Bank loans and overdrafts|**34,887**|43,702| ||===============================|===============================| ## **19. CREDITORS: amounts falling due within one year** ## **20. CREDITORS: amounts falling due after more than one year** 24 25 DocuSign Envelope ID: C02C7E10-0973-43F9-A200-8203256D8AA2 ## **MARS ORG. LTD** ## **COMPANY LIMITED BY GUARANTEE** ## **NOTES TO THE FINANCIAL STATEMENTS** _**(continued)**_ ## **YEAR ENDED 31 DECEMBER 2021** ## **21. ANALYSIS OF CHARITABLE FUNDS** ## **Unrestricted funds** |**Unrestricted funds**||||| |---|---|---|---|---| ||At 1|||**At 31**| ||January|||**December**| ||2021|Income|Expenditure|**2021**| ||£|£|£|**£**| |General funds|212,468|507,584|(498,054)|**221,998**| ||=====================================|=====================================|=====================================|=====================================| ||At 1|||At 31| ||January|||December| ||2020|Income|Expenditure|2020| ||£|£|£|£| |General funds|43,545|1,024,743|(855,820)|212,468| ||===============================|===============================================|=====================================|=====================================| |**Restricted funds**||||| ||At 1|||**At 31**| ||January|||**December**| ||2021|Income|Expenditure|**2021**| ||£|£|£|**£**| |Restricted Funds|94,648|392,529|(385,005)|**102,172**| ||===============================|=====================================|=====================================|=====================================| ||At 1|||At 31| ||January|||December| ||2020|Income|Expenditure|2020| ||£|£|£|£| |Restricted Funds|–|383,383|(288,735)|94,648| ||================|=====================================|=====================================|===============================| ## **Restricted funds** ## **MARS ORG. LTD** ## **COMPANY LIMITED BY GUARANTEE** ## **NOTES TO THE FINANCIAL STATEMENTS** _**(continued)**_ ## **YEAR ENDED 31 DECEMBER 2021** ## **23. ANALYSIS OF CHANGES IN NET DEBT** At **At** 1 Jan 2021 Cash flows **31 Dec 2021** £ £ **£** Cash at bank and in hand 341,709 (258,055) **83,654** Debt due within one year (6,299) (3,301) **(9,600)** Debt due after one year (43,702) 8,815 **(34,887)** ------------------------------------------------------------------------------------------------------291,708 (252,541) **39,167** ===================================== ===================================== =============================== ## **24. RELATED PARTIES** There have been no related party transactions in the reporting period that require disclosure. ## **22. ANALYSIS OF NET ASSETS BETWEEN FUNDS** ||Unrestricted|Restricted|**Total Funds**| |---|---|---|---| ||Funds|Funds|**2021**| ||£|£|**£**| |Tangible fixed assets|62,298|–|**62,298**| |Current assets|266,771|102,172|**368,943**| |Creditors less than 1 year|(72,184)|–|**(72,184)**| |Creditors greater than 1 year|(34,887)|–|**(34,887)**| ||-------------------------------------|-------------------------------------|-------------------------------------| |**Net assets**|221,998|102,172|**324,170**| ||=====================================|=====================================|=====================================| ||Unrestricted|Restricted|Total Funds| ||Funds|Funds|2020| ||£|£|£| |Tangible fixed assets|36,438|–|36,438| |Current assets|252,350|94,648|346,998| |Creditors less than 1 year|(32,618)|–|(32,618)| |Creditors greater than 1 year|(43,702)|–|(43,702)| ||-------------------------------------|-------------------------------|-------------------------------------| |**Net assets**|212,468|94,648|307,116| ||=====================================|===============================|=====================================| 26 27 DocuSign Envelope ID: C02C7E10-0973-43F9-A200-8203256D8AA2 Trustees: Rabbi H Grunfeld Mr J Herzka Mr P Weinberger Bankers: HSBC UK 465 Bethnal Green Road Bethnal Green London E2 9QW Accountants: Messrs Cohen Arnold New Burlington House 1075 Finchley Road London NW11 0PU Organisation Details: MARS ORG. LTD Unit 15 Grosvenor Way London, E5 9ND 020-3322-8586 www.marsorg.com mail@marsorg.com Registered Company Number: 08321795 Registered Charity Number: 1152340 Registered Office: New Burlington House,1075 Finchley Road London NW11 0PU